Answers are grounded in this paper and cite their sources.
Descriptive observational study details clinical progression of metastatic ameloblastoma, highlighting treatment challenges.
Metastatic ameloblastoma is an extremely rare entity representing less than 2% of all ameloblastomas. The condition is even more uncommon when associated with significant neurological involvement. Through the analysis of secondary data, we conducted a descriptive observational study and reported the case of a young female patient with a history of mandibular ameloblastoma, initially treated with local excision, who over the years went through multiple recurrences, culminating in extensive pulmonary metastasis, bone infiltration, optic nerve invasion and ultimately spinal cord compression. She underwent one cycle of chemotherapy and presented febrile neutropenia, followed by sepsis and ultimately death. This study aims to contribute to the clinical documentation of this neoplastic entity, highlighting aspects related to clinical presentation, progression and available therapeutic approaches. A literature review was conducted using the Web of Science database, focusing on publications from 2020 to 2025, and using the following search terms: "metastatic ameloblastoma," "metastasizing ameloblastoma," "atypical ameloblastoma," "malignant ameloblastoma," and "ameloblastic carcinoma." Nine relevant original and review articles were included. The findings confirm the unpredictable nature of metastatic ameloblastoma and the diagnostic challenges, especially due to the lack of clear histopathological markers for this disease. Given the scarcity of specific guidelines, this report contributes to the body of literature on this condition and to the understanding of its unpredictable clinical behavior, as well as supporting more individualized therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Dal-Mora et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: